학술논문
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma
Document Type
Article
Author
McNamara, Mairéad G.; Swain, Jayne; Craig, Zoe; Sharma, Rohini; Faluyi, Olusola; Wadsley, Jonathan; Morgan, Carys; Wall, Lucy R.; Chau, Ian; Reed, Nick; Sarker, Debashis; Margetts, Jane; Krell, Daniel; Cave, Judith; Sothi, Sharmila; Anthoney, Alan; Bell, Christopher; Patel, Alkesh; Oughton, Jamie B.; Cairns, David A.; Mansoor, Wasat; Lamarca, Angela; Hubner, Richard A.; Valle, Juan W.
Source
In eClinicalMedicine June 2023 60
Subject
Language
ISSN
2589-5370